Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 37-41

  Gil, J P ^a   Lechner, M C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DETOXIFICATION; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PORTUGAL; REFERENCE VALUES;

EID: 0011336877     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.37     Document Type: Article

References (31)

1. Hein, D.W. (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948, 37-66.
2. Hein, D.W., Doll, M.A., Gray, K., Rustan, T.D. and Ferguson, R.J. (1993) Metabolic activation of N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamster congenic at the NAT2 locus. Cancer Res., 53, 509-514.
3. Vatsis, K.P., Weber, W.W., Bell., D.A. et al. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-18.
4. Cascorbi, I., Drakoulis, N., Brockmoller, J., Maurer, A., Sperling, K. and Roots, I. (1995) Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet., 57, 581-592.
5. Risch, A., Wallace, D.M.A., Bathers, A. and Sim, E.. (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum. Mol. Genet., 4, 231-236.
6. Brockmoller, J., Cascorbi, I., Kerb, R. and Roots, I. (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione 5-transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res., 56, 3915-3925.
7. Cascorbi, I., Brockmoller, J., Mrozikiewicz, P.M., Baurer, S., Loddenkemper, R. and Roots, I. (1996) Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor of lung cancer. Cancer Res., 56, 3961-3966.
8. Lang, N.P., Chu, D.Z.J., Hunter, C.F., Kendall., D.C., Flammang, T.J. and Kadlubar, F.D. (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg., 121, 1259-1261.
9. Illet, K.F., David, B.M., Detchon, P., Castleden, W.N. and Kwa, R. (1987) Acetylation phenotype in colorectal carcinoma. Cancer Res., 47, 1466-1469.
10. Wholleb, J.C., Hunter, C.F., Blass, B., Kadlubar, F.F., Chu, D.Z. and Lang, N.P. (1990) Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int. J. Cancer, 46, 22-30.
11. Roberts-Thomson, I.C., Ryan, P., Khoo, K.K., Hart, W.J., McMichael, A.J. and Butler, R.N. (1996) Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet, 347, 1372-1374.
12. Feng, Y., Wagner, R.J., Fretland, A.J., Becker, W.K., Cooley, A.M., Pretlow, T.P., Lee, K.J. and Hein, D.W. (1996) Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl. Cancer Res., 56, 527-531.
13. Ambrosone, C.B., Freudenheim, J.L., Graham, S. et al. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA, 276, 1494-1501.
14. Kleman, M., Overvik, E., Mason, G. and Gustafsson, J. A. (1990) Effects of the food mutagens MelQx and PhIP on the expression of cytochrome P450 1A proteins in various tissues of male and female rats. Carcinogenesis, 11, 2185-2189.
15. Rodrigues, A.D., Ayrton, A.D., Williams, E.J., Lewis, D.F.V., Walker, R. and Ioannidis, C. (1989) Preferential induction of rat hepatic P450I proteins by the food carcinogen 3-amino-3-methyl-imidazo(4,5-f)quinoline. Eur. J. Biochem., 81, 627-631.
16. Degawa, M., Tanimuta, S., Agatsuma, T. and Hashimoto, Y. (1989) Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (CYP1A2) responsible for mutagenic activation of the carcinogens in rat liver. Carcinogenesis, 10, 1119-1122.
17. Hein, W.D., Doll, M.A., Rustan, T.D., Gray, K., Feng, Y., Ferguson, R.J and Grant, D.M. (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis, 14, 1633-1638.
18. Illet, K.F., Ingram, D.M., Carpenter, D.S., Teitel, C.H., Lang, N.P., Kadlubar, F.F. and Minchin, R.F. (1994) Expression of monomorphic and polymorphic N-acetyltransferase in human colon. Biochem. Pharmacol., 47, 914-917.
19. Rodriguez, J.W., Kirlin, W.G., Ferguson, M.A. et al. (1993) Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch. Toxicol., 67, 445-452.
20. Bell, D.A., Stephens, E.A., Castranio, T. et al. (1995) Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55, 3537-3542.
21. Spurr, N.K., Gough, A.C., Chinegwundoh, F.I. and Smith, C.A.D. (1995) Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk. Clin. Chem., 41, 1864-1869.
22. Shibuta, K., Nakashima, T., Abe, M., Mashimo, M., Mori, M., Ueo, H., Akiyoshi, T., Sugimachi, K. and Suzuki, T. (1994) Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer, 74, 3108-3112.
23. Lin, H.J., Han, C.-Y., Lin, B.K. and Hardy, S. (1994) Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics, 4, 125-134.
24. Zhao, B., Lee, E.J.D., Wong, J.Y.Y., Yeoh, P.N. and Gong, N.H. (1995) Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays. Pharmacogenetics, 5, 275-278.
25. Weber, W.W. and Hein, D.W. (1985) N-acetylation pharmacogenetics. Pharmacol. Rev., 37, 25-79.
26. Evans, D.A.P. (1992) N-acetyltransferase. In Kalow, W. (ed.) Pharmacogenetics of Drug Metabolism. Pergamon Press, New York, pp. 95-178.
27. Miller, E.C. and Miller, J.A. (1986) Carcinogens and mutagens that may occur in foods. Cancer Res., 58, 1795-1803.
28. Smith, C.A.D., Gough, A.C., Leigh, P.N. et al. (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet, 339, 1375-1377.
29. Agundez, J.A.G., Olivera, M., Martínez, C., Ladero, J.M. and Benítez, J. (1996) Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a White population. Pharmacogenetics, 6, 423-428.
30. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
31. Amorim-Cruz, J.A. (1991) A situação nutricional da população Portuguesa: balanço das últimas três décadas. Rev. Port. Nutrição, 3, 7-15.